02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 0.69
−4.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 3.69x
- P/E 2028E
- 1.46x
- P/S forward
- 2.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.30x
- Price / sales
- 0.64x
- Price / cash flow
- -0.94x
Enterprise value
- Enterprise value
- -HKD 162.5M
- EV / sales
- -0.42x
- EV / EBITDA
- 0.62x
- EV / EBIT
- 0.52x
- Market cap
- HKD 251.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026